Impact Therapeutics

Company snapshot

Headquartered in the commercial capital of India in Mumbai, Impact Therapeutics Limited is one of India’s fastest growing research driven Global Pharmaceutical company specializing in intermediates & advanced intermediates of Active Pharmaceutical Ingredients (APIs). Impact Therapeutics Limited is engaged in the complex business of Contract Research and Manufacturing Services (CRAMS) under loan li

• 12 active pipeline program(s) linked via ClinicalTrials.gov.
• 12 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Impact Therapeutics. Not investment advice.

• Peer + 0 momentum

  HOFFMANN-LA ROCHE

  TA overlap score 40

Recent activity

Latest pipeline, patent, and corporate events for Impact Therapeutics.

1. Jun 8, 2026 Clinical update

   JNJ-73841937 for Patients with EGFR-mutant (L858… — Phase 2

2. Jun 8, 2026 Clinical update

   IBCSG 59-19 — Phase 3

3. Jun 8, 2026 Clinical update

   ETOP 23-22 RAISE — Phase 2

4. Jun 8, 2026 Clinical update

   67-22 PREcoopERA — Phase 2

5. Jun 8, 2026 Clinical update

   ETOP25-23 ADOPT-lung — Phase 3

View all clinical trial activity →

• What is Impact Therapeutics?

  Partner Therapeutics is a pharma organization headquartered in GB. Primary therapeutic focus areas include Breast Cancer, NSCLC, synchronous oligo-metastatic, Solid Tumors, ER-positive/HER2-negative early breast cancer, Extensive-disease small cell lung cancer and high SLFN11-exp

• Is Impact Therapeutics publicly traded?

  Impact Therapeutics appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Impact Therapeutics develop or market?

  We link 26 drug profile(s) where Impact Therapeutics is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/partner-therapeutics-limited#company-drugs.

• What are the latest developments for Impact Therapeutics?

  In the last 12 months our linked public records show 12 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Impact Therapeutics focus on?

  Impact Therapeutics focuses on Breast Cancer, NSCLC, synchronous oligo-metastatic, Solid Tumors based on our analysis of their pipeline programs and drug development activities.